Morgan Lewis is pleased to announce that the 2008 edition of Chambers USA: America’s Leading Lawyers for Business features Morgan Lewis as a leading national firm in 19 practice areas.

Morgan Lewis is pleased to announce the launch of the second edition of the Emerging Life Sciences Companies Deskbook.

Morgan Lewis ranked in ^PLCCross-border Quarterly 2008 Life Sciences Legal Market Review.

Morgan Lewis today announced the addition of Thomas E. Duley—formerly the head of the transactional legal group at PDL BioPharma, Inc.—as of counsel, resident in the firm’s San Francisco office.

Natalie Kingston is quoted on the future of the CRO industry.

141 Morgan Lewis lawyers have been recognized in The Best Lawyers in America 2008.

Morgan Lewis is pleased to announce that the firm has received the Minority Corporate Counsel Association’s (MCCA) Thomas L. Sager Award for the Western Region.

Morgan Lewis is pleased to announce that the 2007 edition of Chambers USA: America’s Leading Lawyers for Business will feature 109 Morgan Lewis lawyers when it is published later this year.

Morgan Lewis is pleased to announce that William Jackson (Jack) Matney, Jr. and Robert W. (Bob) Busby have joined the firm as partners in the Washington, D.C. office. Mr. Matney and Mr. Busby focus on patent litigation and related patent services.

Morgan Lewis is pleased to announce that Andrew Ruskin has brought his healthcare regulatory practice to the firm. Mr. Ruskin counsels clients on the full array of regulatory issues affecting the healthcare industry.

Morgan Lewis is pleased to announce that the Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the ^PLCCross-border Life Sciences Handbook 2006/07.

Morgan Lewis attorneys represented the Carnegie Institution of Washington before the U.S. Patent & Trademark Office in obtaining U.S. Patent 6,506,559, which claims the subject matter awarded the Nobel Prize in Medicine for 2006.

Morgan Lewis is pleased to announce the addition of five partners and five associates to its global Intellectual Property Practice as of December 1.

On August 2, 2006, United States District Judge William Bassler entered a judgment on behalf of Morgan Lewis clients Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Inc.

On June 22, 2006 the Intellectual Property (IP) Law Section of the American Bar Association (ABA) held its summer meeting in Boston. Resolution 413-1, entitled State Prescription Drug Compulsory Licensing was presented, debated, and overwhelmingly passed.

Morgan Lewis sponsors BIO 2006, the world's largest gathering of biotechnology leaders.

Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the ^PLCCross-border Life Sciences Handbook 2005/06.

Morgan Lewis & Bockius LLP, a global law firm, today announced a new joint venture with TMI Associates, one of the top law firms in Japan, effective immediately. The new partnership, named Morgan Lewis-TMI, will focus primarily on cross-border corpora

Seventy-six Morgan Lewis lawyers and 35 of the firm’s practice areas have been included in the latest annual edition of Chambers USA America’s Leading Business Lawyers.

Morgan Lewis announced today the addition of seven premier lawyers from Wilmer Cutler Pickering Hale and Dorr LLP, who will join the Business and Finance Practice in the firm’s Princeton, New Jersey office.